Zobrazeno 1 - 10
of 24
pro vyhledávání: '"P. GARY KATZ"'
Publikováno v:
Journal of Urology. 155:915-917
Purpose: We determined the long-term efficacy of intracavernous injection of a new formulation of prostaglandin E1 (Caverject* *The Upjohn Co., Kalamazoo, Michigan.) as treatment for erectile failure.Materials and Methods: A prospective study was don
Publikováno v:
Journal of Urology. 154:77-79
Purpose: We determined the incidence of pain with injection of a new formulation of prostaglandin E1.Materials and Methods: A total of 63 subjects with erectile dysfunction underwent treatment with the new formulation of prostaglandin E1. Evidence of
Publikováno v:
Journal of Urology. 153:650-652
Sexual interest and activity decrease following castration. We determined by objective criteria the erectile status of 16 men who were sexually active before castration for prostatic cancer. Castration was achieved by orchiectomy or hormonal manipula
Autor:
Michael Godschalk, Kenneth A. Unice, Donald Bergner, Thomas Mulligan, P. Gary Katz, John Mcmichael
Publikováno v:
The Journal of urology. 170(4 Pt 1)
Human chorionic gonadotropin (HCG) is a glycoprotein hormone with multiple physiological functions. It interferes with mammary tumorigenesis and modulates growth and tumorigenesis in prostate cancer cells. In addition, HCG receptor transcripts and pr
Publikováno v:
Journal of Urology. 144:694-696
Between March 1983 and December 1988, 66 men 50 years old and older with symptomatic bladder outlet obstruction underwent transurethral incision of the bladder neck and prostate. Patients selected for incision had a small, clinically benign, prostate
Publikováno v:
The Journal of urology. 153(1)
The recommended dose of prostaglandin E1 as treatment for erectile dysfunction has been reported to be 10 to 40 micrograms. However, adverse effects probably increase with increasing doses. We conducted a prospective, single-blind, dose-escalating st
Publikováno v:
Journal of the American Geriatrics Society. 42(12)
OBJECTIVE: To determine the efficacy of intracavernosal injection of prostaglandin E1(alprostadil) in elderly men with erectile failure. DESIGN: Prospective study. SETTING: Outpatients at a university-affiliated VA Medical Center. PARTICIPANTS: Ten s
Autor:
Meena Midha, Alexander Greenstein, Victoria Marcelino, P. Gary Katz, Linda K. Jones, Edward S. Wong
Publikováno v:
Urology. 43(6)
Objective. Recurrent urinary tract infections are common in spinal-cord-injured patients. Our study was designed to evaluate the association of bacteria colony counts, white blood cell (WBC) count, and antibody-coated bacteria analyzed in urethral an
Publikováno v:
The Journal of urology. 151(6)
We report a double-blind, randomized, placebo-controlled, dose-response study of prostaglandin E1 as treatment for erectile failure. A total of 15 men 55.8 +/- 9.2 years old with a mean duration of erectile dysfunction of 7.6 years participated. Duri
Publikováno v:
Annals of vascular surgery. 5(3)
Arterial-ureteral fistula, a rare cause of gross hematuria, may be associated with life-threatening hemorrhage if not rapidly diagnosed and treated. Recently, a patient at the Hunter H. McGuire Veterans Administration Medical Center developed an arte